Cadrenal Therapeutics
CVKD
#11070
Rank
HK$36.7 M
Marketcap
HK$11.85
Share price
0.00%
Change (1 day)
-86.97%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2026 (TTM): -HK$41.97

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$42.05. In 2025 the company made an earnings per share (EPS) of -HK$52.09 an increase over its 2024 EPS that were of -HK$68.49.

EPS history for Cadrenal Therapeutics from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$41.97-19.44%
2025-HK$52.09-23.94%
2024-HK$68.49-6.03%
2023-HK$72.88